JPWO2022061368A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022061368A5 JPWO2022061368A5 JP2023518033A JP2023518033A JPWO2022061368A5 JP WO2022061368 A5 JPWO2022061368 A5 JP WO2022061368A5 JP 2023518033 A JP2023518033 A JP 2023518033A JP 2023518033 A JP2023518033 A JP 2023518033A JP WO2022061368 A5 JPWO2022061368 A5 JP WO2022061368A5
- Authority
- JP
- Japan
- Prior art keywords
- herv
- binding protein
- antibody
- binding
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063080009P | 2020-09-17 | 2020-09-17 | |
| PCT/US2021/071505 WO2022061368A2 (en) | 2020-09-17 | 2021-09-18 | Herv-k antibody therapeutics |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023547313A JP2023547313A (ja) | 2023-11-10 |
| JPWO2022061368A5 true JPWO2022061368A5 (https=) | 2024-10-03 |
| JP2023547313A5 JP2023547313A5 (https=) | 2024-10-03 |
| JP7810446B2 JP7810446B2 (ja) | 2026-02-03 |
Family
ID=80776422
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518033A Active JP7810446B2 (ja) | 2020-09-17 | 2021-09-18 | Ｈｅｒｖ－ｋ抗体治療薬 |
| JP2024516706A Pending JP2024541175A (ja) | 2020-09-17 | 2022-09-16 | Ｈｅｒｖ－ｋ抗体治療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516706A Pending JP2024541175A (ja) | 2020-09-17 | 2022-09-16 | Ｈｅｒｖ－ｋ抗体治療法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20240059787A1 (https=) |
| EP (2) | EP4213881A4 (https=) |
| JP (2) | JP7810446B2 (https=) |
| CN (2) | CN116457018A (https=) |
| CA (1) | CA3195886A1 (https=) |
| WO (2) | WO2022061368A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024148216A2 (en) * | 2023-01-05 | 2024-07-11 | Neximmune, Inc. | Combination therapy with t cell engager |
| WO2025222129A2 (en) * | 2024-04-19 | 2025-10-23 | Mozart Therapeutics, Inc. | Engineered cytokines and targeted cytokine delivery |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060275747A1 (en) * | 2001-12-07 | 2006-12-07 | Hardy Stephen F | Endogenous retrovirus up-regulated in prostate cancer |
| US20090297530A1 (en) * | 2006-05-22 | 2009-12-03 | Feng Wang-Johanning | Herv-k antigens, antibodies, and methods |
| US20080019979A1 (en) * | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| US20110091544A1 (en) | 2009-10-16 | 2011-04-21 | Acelrx Pharmaceuticals, Inc. | Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting |
| TWI487537B (zh) * | 2010-06-09 | 2015-06-11 | Nat Health Research Institutes | 對抗腸病毒７１型之單株抗體及其用途 |
| US20140121123A1 (en) * | 2010-10-29 | 2014-05-01 | Kevin Caili Wang | Methods for diversifying antibodies, antibodies derived therefrom and uses thereof |
| EP3783098A1 (en) * | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| CA2927022C (en) | 2013-10-11 | 2018-08-21 | Asana Biosciences, Llc | Protein-polymer-drug conjugates |
| US12016882B2 (en) * | 2017-11-22 | 2024-06-25 | The Brigham And Women's Hospital, Inc. | Method of treating glioblastoma multiforme |
| KR20210087938A (ko) * | 2018-09-28 | 2021-07-13 | 이미지냅 인코포레이티드 | Cd8 이미징 구조체 및 이의 사용 방법 |
| US20250145693A1 (en) * | 2021-09-18 | 2025-05-08 | Sunnybay Biotech, Inc. | Herv-k antibody, cell, vaccine, and drug therapeutics |
-
2021
- 2021-09-18 CA CA3195886A patent/CA3195886A1/en active Pending
- 2021-09-18 US US18/245,879 patent/US20240059787A1/en active Pending
- 2021-09-18 EP EP21870462.5A patent/EP4213881A4/en active Pending
- 2021-09-18 WO PCT/US2021/071505 patent/WO2022061368A2/en not_active Ceased
- 2021-09-18 JP JP2023518033A patent/JP7810446B2/ja active Active
- 2021-09-18 CN CN202180077370.3A patent/CN116457018A/zh active Pending
-
2022
- 2022-09-16 CN CN202280062721.8A patent/CN118103071A/zh active Pending
- 2022-09-16 US US18/692,754 patent/US20240374644A1/en active Pending
- 2022-09-16 EP EP22871001.8A patent/EP4401779A4/en active Pending
- 2022-09-16 JP JP2024516706A patent/JP2024541175A/ja active Pending
- 2022-09-16 WO PCT/US2022/076624 patent/WO2023044465A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502104A5 (https=) | ||
| JP2018508475A5 (https=) | ||
| JP2020534830A5 (https=) | ||
| JP2020508334A5 (https=) | ||
| JP2018506961A5 (https=) | ||
| JPWO2019175217A5 (https=) | ||
| JP2019525771A5 (https=) | ||
| JP2015163068A5 (https=) | ||
| JP2022169504A5 (https=) | ||
| JPWO2019175220A5 (https=) | ||
| JP2018505681A5 (https=) | ||
| JPWO2019175215A5 (https=) | ||
| JPWO2019175224A5 (https=) | ||
| JP2020534012A5 (https=) | ||
| CN112135842B (zh) | 用于治疗患有再活化现象相关疾病的爱泼斯坦-巴尔病毒阳性患者的药物制剂 | |
| JP2018528776A5 (https=) | ||
| JP2018530331A5 (https=) | ||
| JPWO2020132024A5 (https=) | ||
| CN115038718A (zh) | 抗人程序性死亡配体-1（pd-l1）的抗体及其用途 | |
| JPWO2020183245A5 (https=) | ||
| JPWO2022044573A5 (https=) | ||
| JPWO2022061368A5 (https=) | ||
| JPWO2020227457A5 (https=) | ||
| US20260055201A1 (en) | Bispecific antibody and use thereof | |
| WO2024165049A1 (zh) | 抗cdh6的抗体及其用途 |